Erasca is a biotechnology company that is developing precision therapies for the treatment of cancer. The company was founded in 2018 and is headquartered in San Diego, California. Erasca's approach is to target specific genetic mutations that drive cancer growth, with the goal of developing more effective and less toxic treatments. The company has a pipeline of drug candidates in various stages of development, and has raised over $300 million in funding from investors. Erasca's mission is to improve the lives of cancer patients by developing innovative therapies that target the underlying causes of the disease.